Trillsch, F., Mahner, S., Hilpert, F., Davies, L., Garcia-Martinez, E., Kristensen, G., Savarese, A., Vuylsteke, P., Los, M., Zagouri, F., Gebski, V., Lee, C., et al (2016). Prognostic and predictive effects of primary versus secondary platinum resistance for bevacizumab treatment for platinum-resistant ovarian cancer in the AURELIA trial. Annals of Oncology, 27(9), 1733-1739. [More Information]